Overview
CBRE Group, Inc., headquartered in the United States, operates as a premier global real estate services firm. It is a key player in the commercial real estate industry and provides a broad range of services including property sales and leasing, facilities and project management, investment management, appraisal and valuation, and strategic consulting. CBRE is notable for its extensive operational reach, managing numerous high-profile projects across various continents. These include significant urban and commercial developments, which showcase its prowess in handling large-scale real estate operations and investment activities. As the largest commercial real estate services company in the world, CBRE leverages its global presence to offer superior insights and services that enhance property value and promote strategic real estate development.
Basic Stats
The share price of CBRE Group, Inc. as of 5 September 2025 is US$163.05 / share. This is an increase of 0.50% from the prior week. The market cap (or net worth) of CBRE Group, Inc. as of 5 September 2025 is US$46,902.47 MM.
The Factor Analysis chart (below right) shows a view of CBRE Group, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 46,902.47 MM |
| EV | 53,452.47 MM |
| Shares Out. | 293.07 MM |
| Earnings Date | |
| EPS (TTM) | 3.72 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 40.15 % |
| Volatility (1 yr) | 0.31 |
| Beta | 1.20 |
| Sharpe Ratio (1 yr) | 1.14 |
| Sortino Ratio (1 yr) | 1.97 |
| PE Ratio | 43.03 |
| Price/Book | 5.22 |
| Price/TBV | -73.06 |
| Book/Market | 0.19 |
| EBIT/EV | 0.03 |
| EBIT(3yr avg)/EV | 0.02 |
| ROA | 0.05 |
| ROE | 0.12 |
| ROIC | 0.06 |
| CROIC | 0.03 |
| OCROIC | 0.08 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 52.73 /100 |
| Profitability | 63.24 /100 |
| Quality Score | 47.12 /100 |
| Value Score | 48.84 /100 |
| Momentum Score | 64.74 /100 |
| Stability (Low Vol) Score | 70.03 /100 |
| Analyst Sentiment | 20.98 /100 |
| Fund Sentiment | 39.82 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 8.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for CBRE Group, Inc. is US$165.58. The forecasts range from a low of US$114.79 to a high of US$205.99. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for CBRE Group, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-03 | UBS | Neutral | Neutral | Maintains |
| 2024-04-10 | Jefferies | Hold | Initiate | |
| 2024-04-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-02-16 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2024-01-25 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2024-01-03 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2023-11-22 | UBS | Neutral | Neutral | Maintains |
| 2023-10-04 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2023-09-18 | Citigroup | Buy | Buy | Maintains |
| 2023-09-14 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2023-09-11 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2023-07-28 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2023-07-24 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2023-05-23 | Citigroup | Buy | Buy | Maintains |
| 2023-04-24 | Keefe, Bruyette & Woods | Market Perform | Maintains | |
| 2023-04-11 | Goldman Sachs | Buy | Maintains | |
| 2023-04-10 | Goldman Sachs | Buy | Maintains | |
| 2023-03-28 | Citigroup | Buy | Maintains | |
| 2023-03-03 | JP Morgan | Neutral | Maintains | |
| 2023-01-27 | Citigroup | Buy | Initiate | |
| 2023-01-27 | Keefe, Bruyette & Woods | Outperform | Market Perform | Downgrade |
| 2023-01-20 | Raymond James | Strong Buy | Maintains | |
| 2022-10-20 | Raymond James | Strong Buy | Maintains | |
| 2022-10-19 | Goldman Sachs | Buy | Maintains | |
| 2022-08-05 | Raymond James | Strong Buy | Maintains | |
| 2022-07-22 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2022-05-06 | Raymond James | Outperform | Maintains | |
| 2022-04-26 | Raymond James | Outperform | Maintains | |
| 2022-03-10 | Wolfe Research | Outperform | Maintains | |
| 2022-02-25 | Raymond James | Outperform | Maintains | |
| 2022-01-21 | Raymond James | Outperform | Maintains | |
| 2021-11-23 | Keefe, Bruyette & Woods | Market Perform | Outperform | Upgrade |
| 2021-10-22 | Raymond James | Outperform | Maintains | |
| 2021-07-30 | Raymond James | Outperform | Maintains | |
| 2021-06-15 | Wolfe Research | Outperform | Initiate | |
| 2021-04-30 | Raymond James | Outperform | Maintains | |
| 2021-04-27 | Raymond James | Outperform | Maintains | |
| 2021-01-22 | Raymond James | Outperform | Maintains | |
| 2020-11-02 | UBS | Neutral | Maintains | |
| 2020-10-30 | Raymond James | Outperform | Maintains | |
| 2020-08-11 | UBS | Neutral | Maintains | |
| 2020-07-29 | Raymond James | Outperform | Maintains | |
| 2020-05-13 | UBS | Neutral | Maintains | |
| 2020-05-08 | CFRA | Hold | Sell | Downgrade |
| 2020-05-08 | Keefe, Bruyette & Woods | Market Perform | Maintains | |
| 2020-04-09 | JP Morgan | Overweight | Neutral | Downgrade |
| 2020-02-28 | UBS | Neutral | Maintains | |
| 2020-01-24 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2019-08-12 | UBS | Neutral | Maintains | |
| 2019-08-02 | Raymond James | Strong Buy | Maintains | |
| 2019-07-11 | Compass Point | Neutral | Initiate | |
| 2019-01-03 | Bank of America | Buy | Neutral | Downgrade |
| 2018-11-02 | Bank of America | Buy | Buy | Maintains |
| 2018-08-30 | Barclays | Overweight | Overweight | Maintains |
| 2018-05-14 | Barclays | Overweight | Overweight | Maintains |
| 2018-05-10 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2018-04-03 | Goldman Sachs | Buy | Initiate | |
| 2018-03-15 | Barclays | Overweight | Overweight | Maintains |
| 2018-03-06 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-02-06 | Raymond James | Outperform | Initiate | |
| 2018-01-30 | Barclays | Overweight | Overweight | Maintains |
| 2018-01-24 | JMP Securities | Market Outperform | Market Perform | Downgrade |
| 2018-01-22 | Evercore ISI Group | In-Line | Initiate | |
| 2017-11-06 | Bank of America | Buy | Maintains | |
| 2017-08-15 | Barclays | Overweight | Maintains | |
| 2017-07-26 | UBS | Neutral | Initiate | |
| 2017-07-18 | Barclays | Overweight | Maintains | |
| 2016-10-06 | Wedbush | Outperform | Initiate | |
| 2016-05-16 | Keefe Bruyette & Woods | Market Perform | Initiate | |
| 2015-10-20 | Barclays | Overweight | Maintains | |
| 2015-09-03 | Barclays | Overweight | Maintains | |
| 2015-08-26 | Sterne Agee CRT | Buy | Initiate | |
| 2015-04-01 | JMP Securities | Market Outperform | Maintains | |
| 2015-03-04 | JP Morgan | Overweight | Maintains | |
| 2015-01-22 | Barclays | Overweight | Maintains | |
| 2014-12-18 | JP Morgan | Overweight | Maintains | |
| 2014-12-04 | Barclays | Overweight | Maintains | |
| 2014-10-14 | JP Morgan | Overweight | Maintains | |
| 2014-07-30 | Jefferies | Market Outperform | Maintains | |
| 2014-07-21 | Barclays | Overweight | Maintains | |
| 2014-07-17 | JP Morgan | Overweight | Maintains | |
| 2014-06-16 | JMP Securities | Market Outperform | Maintains | |
| 2014-05-06 | Barclays | Overweight | Maintains | |
| 2014-03-06 | Goldman Sachs | Buy | Initiate | |
| 2014-03-06 | JP Morgan | Overweight | Maintains | |
| 2014-02-06 | Bank of America | Buy | Maintains | |
| 2012-10-22 | Barclays | Overweight | Maintains | |
| 2012-08-07 | Barclays | Overweight | Maintains | |
| 2012-08-01 | S&P Capital IQ | Buy | Hold | Downgrade |
| 2024-12-16 | JP Morgan | Neutral | Overweight | Upgrade |
| 2025-08-26 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-02-19 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-11-25 | Citigroup | Buy | Buy | Maintains |
| 2024-08-01 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2025-04-11 | UBS | Neutral | Neutral | Maintains |
| 2025-04-10 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-10-29 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2025-01-15 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2024-10-04 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-07-26 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2024-07-25 | Morgan Stanley | Equal-Weight | Initiate | |
| 2024-07-25 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2024-07-25 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2025-02-14 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2025-07-30 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-01-24 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2025-04-24 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-01-13 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-12-06 | Goldman Sachs | Buy | Initiate | |
| 2025-04-30 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2025-01-02 | Jefferies | Hold | Buy | Upgrade |
| 2025-04-17 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2025-07-02 | UBS | Neutral | Neutral | Maintains |
| 2025-06-12 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-07-24 | Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintains |
| 2025-07-24 | Raymond James | Outperform | Outperform | Maintains |
| 2025-08-25 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-07-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
